Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Blood. 2012 Apr 12;119(15):3374-6. doi: 10.1182/blood-2012-02-406611.

Advancing the STATus of MPN pathogenesis.

Author information

  • 1University of California, San Francisco, CA, USA.

Abstract

In this issue of Blood, Yan et al and Walz et al exploit mouse genetics to investigate the contribution of signal transducer and activator of transcription 5 (STAT5) to the abnormal in vivo growth of hematopoietic cells expressing JAK2(V617F) or BCR-ABL. Eliminating STAT5 expression had dramatic effects in both contexts, and this new work and other recent studies support the therapeutic potential of targeting pathways regulated by this important signaling molecule in patients with myeloproliferative neoplasms (MPNs).

Comment on

PMID:
22500049
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk